2-134458150-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PM1PP2BP4BS2
The NM_030923.5(TMEM163):c.691G>A(p.Val231Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030923.5 missense
Scores
Clinical Significance
Conservation
Publications
- leukodystrophy, hypomyelinating, 25Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM163 | ENST00000281924.6 | c.691G>A | p.Val231Met | missense_variant | Exon 7 of 8 | 1 | NM_030923.5 | ENSP00000281924.6 | ||
TMEM163 | ENST00000467316.1 | n.1125G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
TMEM163 | ENST00000476823.1 | n.3947G>A | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251310 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 727240 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74328 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.691G>A (p.V231M) alteration is located in exon 7 (coding exon 7) of the TMEM163 gene. This alteration results from a G to A substitution at nucleotide position 691, causing the valine (V) at amino acid position 231 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at